<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00685542</url>
  </required_header>
  <id_info>
    <org_study_id>H-081-043-232</org_study_id>
    <nct_id>NCT00685542</nct_id>
  </id_info>
  <brief_title>Effect of Diacerein on Hand Osteoarthritis</brief_title>
  <official_title>Phase IV Study of Diacerein in Human Hand Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Myungmoon Pharm. Co.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ostearthritis is one of the most common arthritis, affecting more than 30% of aged people
      world-widely. The disease is characterized by pain and stiffness of the affected joints and
      is the most common cause of disability in aged people. It commonly affects knee, hip, hand
      and spine joints. Diacerein is a drug developed specifically for the treatment of
      osteoarthritis. It has inhibitory effects on interleukin-1 (IL-1) and metalloproteases which
      are known to play key roles in the pathogenesis of osteoarthritis while exerting no effect on
      phospholipase A2, cyclooxygenase or lipoxygenase. It showed anti-inflammatory effects on
      animal models and reduced structural changes in several animal models. Therefore, we
      investigate the role of diacerein in patients with hand osteoarthritis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Australian/Canadian Osteoarthritis Hand Index (AUSCAN) pain score at 4 week point</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AUSCAN stiffness score at 4 week point</measure>
    <time_frame>12wks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUSCAN pain score at 12 week point</measure>
    <time_frame>12wk</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diacerein 50mg bid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo 50mg bid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>diacerein</intervention_name>
    <description>Diacerein 50mg bid</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Atrodar 50mg bid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages over 40 years-old

          -  Conforming to the classification criteria of American College of Rheumatology*

          -  More than 1 tender joints

          -  Self reported hand pain which is more than 30 mm on the Australian/Canadian
             Osteoarthritis Hand Index visual analogue scales (VAS) after wash out period of 2
             weeks

        Exclusion Criteria:

          -  Pregnant or lactating women

          -  Previous history of hypersensitivity to Diacerein

          -  Patients who had taken oral corticosteroid or intraarticular steroid to hand joints
             within 3 months of enrollment

          -  Patients who were injected with hyaluronic acid to hand joints within 6 months of
             enrollment

          -  Patients who underwent surgery in any joints of the hands

          -  AST/ALT &gt; 2x upper normal range

          -  Serum Cr &gt; 1.4 mg/dl

          -  Patients who have severe comorbidities such as severe congestive heart failure or
             pulmonary disease

          -  Patients who took oral anticoagulants.

          -  Patients who refuse to sign the consent form
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eun Bong Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 24, 2008</study_first_submitted>
  <study_first_submitted_qc>May 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2008</study_first_posted>
  <last_update_submitted>December 2, 2010</last_update_submitted>
  <last_update_submitted_qc>December 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2010</last_update_posted>
  <responsible_party>
    <name_title>Seoul National University Hopital</name_title>
    <organization>Eun Bong Lee</organization>
  </responsible_party>
  <keyword>diacerein</keyword>
  <keyword>osteoarthritis</keyword>
  <keyword>hand</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diacetylrhein</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

